Medadvisor Ltd
ASX:MDR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medadvisor Ltd
ASX:MDR
|
AU |
|
N
|
Nielsen Holdings PLC
LSE:0XI7
|
US |
|
DCC PLC
LSE:DCC
|
IE |
|
M
|
Manz AG
XETRA:M5Z
|
DE |
|
Red Electrica Corporacion SA
MAD:RED
|
ES |
|
Silvercrest Asset Management Group Inc
NASDAQ:SAMG
|
US |
|
Appen Ltd
ASX:APX
|
AU |
|
B
|
Bairong Inc
HKEX:6608
|
CN |
|
FinVolution Group
NYSE:FINV
|
CN |
|
Hamborner REIT AG
XETRA:HABA
|
DE |
|
A
|
Arteria SA
WSE:ARR
|
PL |
|
T
|
Tenaga Nasional Bhd
KLSE:TENAGA
|
MY |
|
Titan Company Ltd
NSE:TITAN
|
IN |
|
F
|
Firm Capital Mortgage Investment Corp
TSX:FC
|
CA |
|
C
|
Cannabis Poland SA
WSE:CBD
|
PL |
|
S
|
Sundaram Multi Pap Ltd
NSE:SUNDARAM
|
IN |
|
BTS Group AB
STO:BTS B
|
SE |
|
Real Luck Group Ltd
XTSX:LUCK
|
CA |
|
H
|
Himalaya Energi Perkasa Tbk PT
IDX:HADE
|
ID |
|
Foran Energy Group Co Ltd
SZSE:002911
|
CN |
Medadvisor Ltd
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
Revenue Decline: MedAdvisor's U.S. business saw a significant drop in revenue in Q1 FY '26, driven by regulatory delays, lower vaccine volumes, and overall sector headwinds.
Vaccine Revenue Hit: Vaccine program revenue plunged 90% year-on-year, especially due to weak RSV and COVID demand and regulatory delays.
Gross Margin Pressure: Gross margins softened due to increased platform costs and a shift in product mix.
Cash & Debt: The company has around $13 million cash, all debt discharged, and expects an additional $8 million from a transaction holdback soon.
Specialty Medication Outlook: Specialty medication revenue fell 18%, but management forecasts solid growth in this segment later in FY '26.
Cost Reductions: Operating expenses are targeted to be at least 15% lower in FY '26 versus FY '25.
Strategic Focus Shift: Strategic options review is now closed; management is prioritizing U.S. business transformation and growth.
Pipeline Adjustment: The health program pipeline is now valued at $100 million after cleanup and some conversions.
